Logo image of CLDR

Cloudera Inc (CLDR) Stock Fundamental Analysis

NYSE:CLDR - New York Stock Exchange, Inc. -

15.99  +0.01 (+0.06%)

After market: 16 +0.01 (+0.06%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CLDR. CLDR was compared to 283 industry peers in the Software industry. CLDR may be in some trouble as it scores bad on both profitability and health. CLDR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLDR was profitable.

1.2 Ratios

Industry RankSector Rank
ROA -5.95%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -14.43%
PM (TTM) -15.73%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

There is no outstanding debt for CLDR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CLDR has an Altman-Z score of 1.45. This is a bad value and indicates that CLDR is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.44 indicates that CLDR is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 1.45
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CLDR has a Current Ratio of 1.18. This is a normal value and indicates that CLDR is financially healthy and should not expect problems in meeting its short term obligations.
CLDR has a Quick Ratio of 1.18. This is a normal value and indicates that CLDR is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18

More info and screens

5

3. Growth

3.1 Past

CLDR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 256.25%, which is quite impressive.
CLDR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.38%.
Measured over the past years, CLDR shows a very strong growth in Revenue. The Revenue has been growing by 39.25% on average per year.
EPS 1Y (TTM)256.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)8.38%
Revenue growth 3Y32.66%
Revenue growth 5Y39.25%
Sales Q2Q%10.13%

3.2 Future

CLDR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.66% yearly.
CLDR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.82% yearly.
EPS Next Y20.89%
EPS Next 2Y17.91%
EPS Next 3Y12.61%
EPS Next 5Y10.66%
Revenue Next Year8.99%
Revenue Next 2Y8.33%
Revenue Next 3Y8.37%
Revenue Next 5Y7.82%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLDR Yearly Revenue VS EstimatesCLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
CLDR Yearly EPS VS EstimatesCLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.05, the valuation of CLDR can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.62, CLDR is valued at the same level.
A Price/Forward Earnings ratio of 25.56 indicates a quite expensive valuation of CLDR.
The average S&P500 Price/Forward Earnings ratio is at 22.70. CLDR is around the same levels.
Industry RankSector Rank
PE 28.05
Fwd PE 25.56
CLDR Price Earnings VS Forward Price EarningsCLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 233.78
CLDR Per share dataCLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

CLDR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CLDR's earnings are expected to grow with 12.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.34
PEG (5Y)N/A
EPS Next 2Y17.91%
EPS Next 3Y12.61%

More info and screens

0

5. Dividend

5.1 Amount

CLDR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Cloudera Inc

NYSE:CLDR (10/7/2021, 8:58:51 PM)

After market: 16 +0.01 (+0.06%)

15.99

+0.01 (+0.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.05%
Inst Owner Change0%
Ins Owners14.77%
Ins Owner Change0%
Market Cap4.74B
Analysts60
Price Target16.99 (6.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28.05
Fwd PE 25.56
P/S 5.23
P/FCF N/A
P/OCF N/A
P/B 4.26
P/tB N/A
EV/EBITDA 233.78
EPS(TTM)0.57
EY3.56%
EPS(NY)0.63
Fwd EY3.91%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.05
BVpS3.75
TBVpSN/A
PEG (NY)1.34
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -14.43%
PM (TTM) -15.73%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 1.45
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)256.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y20.89%
EPS Next 2Y17.91%
EPS Next 3Y12.61%
EPS Next 5Y10.66%
Revenue 1Y (TTM)8.38%
Revenue growth 3Y32.66%
Revenue growth 5Y39.25%
Sales Q2Q%10.13%
Revenue Next Year8.99%
Revenue Next 2Y8.33%
Revenue Next 3Y8.37%
Revenue Next 5Y7.82%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A